Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Machine learning identifies microbiome and clinical predictors of sustained weight loss following prolonged fasting.
Impact of age, BMI, and renal function adjustment on interpretation of serum NfL and GFAP in multiple sclerosis progression: a scoping review.
Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis.
Oral supplementation of 6'-sialyllactose in early-life enhances cognitive function in mice via modulating gut microbiota and promoting brain myelination.
Strongyloides hyperinfection complicated by invasive aspergillosis and osmotic demyelination syndrome.
Autotaxin as a potential biomarker in hepatic encephalopathy: Insights from a mouse model and cirrhotic patients.
The effects of abused drugs on ferroptosis pathways: potential therapeutic targets for substance use disorders.
Selegiline induces neuroprotection via PGC-1α/Nrf2 gene upregulation in H2O2 -treated hippocampal-derived neural stem/progenitor cells.
Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.
Minocycline ameliorates CNS autoimmunity through restraint of CD4CD11bc cells.
Microglia and neuroinflammation: An in-depth analysis from functional diversity to disease mechanisms.
Vaccines for Autoimmune Diseases: Stopping Triggers, Restoring BalanceA Systematic Review with Qualitative Synthesis.
Case Report: Gait training using a wearable ankle-exoskeleton in a pediatric patient with Guillain-Barré syndrome.
The cost of imbalance: how balance problems drive energy cost of walking in persons with multiple sclerosis.
Peripheral Neuropathy and Restless Legs Syndrome in Cirrhosis: An Electrophysiological Cross-sectional Study.
A-to-I RNA editing profiles and distinct immune responses in myelin oligodendrocyte glycoprotein antibody-positive optic neuritis.
Analytical validation of a multiplexed peptide microarray for multi-antigen Epstein-Barr virus serological profiling across diverse clinical specimens.
Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time.
Multi-omics Insights into Oxidative Stress-related Genes and Neurodegenerative Diseases: From Epigenetic Regulation to Pathogenic Pathways.
Developmental changes in hypoglossal canal morphometry and its anatomical relationships: a CT study in 180 pediatric patients.
Oligodendrocytes in central nervous system health and disease.
RhoA in postnatal spinal motoneuron is essential for peripheral myelination.
A Study on the Correlation Between Clinical Features of Chronic Relapsing Inflammatory Optic Neuropathy and Myelin Oligodendrocyte Glycoprotein Antibodies.
Stereotactic radiosurgery for craniofacial pain disorders: current clinical applications and future perspectives.
Digital signatures of fatigue and wearing-off symptoms in patients with multiple sclerosis under natalizumab.
Pages
« first
‹ previous
…
1098
1099
1100
1101
1102
1103
1104
1105
1106
next ›
last »